Yubo International Biotech Limited
YBGJ
$0.01
$0.001.43%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.65% | -38.59% | |||
| Depreciation & Amortization | -3.33% | 1.12% | |||
| Other Operating Expenses | 192.41% | -168.56% | |||
| Total Operating Expenses | 24.19% | -46.57% | |||
| Operating Income | -24.19% | 46.57% | |||
| Income Before Tax | -24.23% | 46.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.23% | 46.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 72.16% | -38.80% | |||
| Net Income | -20.19% | 47.13% | |||
| EBIT | -24.19% | 46.57% | |||
| EBITDA | -30.25% | 51.60% | |||
| EPS Basic | 0.00% | 47.22% | |||
| Normalized Basic EPS | 0.00% | 50.00% | |||
| EPS Diluted | 0.00% | 47.22% | |||
| Normalized Diluted EPS | 0.00% | 50.00% | |||
| Average Basic Shares Outstanding | 23.41% | 0.00% | |||
| Average Diluted Shares Outstanding | 23.41% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||